Details for New Drug Application (NDA): 020902
✉ Email this page to a colleague
The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. One hundred and forty suppliers are listed for this compound. Additional details are available on the famotidine profile page.
Summary for 020902
| Tradename: | PEPCID AC |
| Applicant: | J And J Consumer Inc |
| Ingredient: | famotidine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020902
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Aug 5, 1999 | TE: | RLD: | No | |||||
Expired US Patents for NDA 020902
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 4,283,408*PED | ⤷ Get Started Free |
| J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 5,854,267*PED | ⤷ Get Started Free |
| J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 5,667,794*PED | ⤷ Get Started Free |
| J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 4,820,524*PED | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
